684 related articles for article (PubMed ID: 32224633)
1. Botulinum Toxin A Injection in Treatment of Upper Limb Spasticity in Children with Cerebral Palsy: A Systematic Review of Randomized Controlled Trials.
Farag SM; Mohammed MO; El-Sobky TA; ElKadery NA; ElZohiery AK
JBJS Rev; 2020 Mar; 8(3):e0119. PubMed ID: 32224633
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.
Lukban MB; Rosales RL; Dressler D
J Neural Transm (Vienna); 2009 Mar; 116(3):319-31. PubMed ID: 19142573
[TBL] [Abstract][Full Text] [Related]
3. Effects of botulinum toxin injections in the upper limbs of children with cerebral palsy: A systematic review of the literature.
Klein C; Gouron R; Barbier V
Orthop Traumatol Surg Res; 2024 May; 110(3):103578. PubMed ID: 36754169
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
Wasiak J; Hoare B; Wallen M
Cochrane Database Syst Rev; 2004 Oct; (4):CD003469. PubMed ID: 15495055
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE).
Hoare BJ; Wallen MA; Imms C; Villanueva E; Rawicki HB; Carey L
Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD003469. PubMed ID: 20091546
[TBL] [Abstract][Full Text] [Related]
6. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin.
Koman LA; Smith BP; Williams R; Richardson R; Naughton M; Griffin L; Evans P
J Hand Surg Am; 2013 Mar; 38(3):435-46.e1. PubMed ID: 23428186
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
Wasiak J; Hoare B; Wallen M
Cochrane Database Syst Rev; 2004; (3):CD003469. PubMed ID: 15266487
[TBL] [Abstract][Full Text] [Related]
8. Impact of Injection-Guiding Techniques on the Effectiveness of Botulinum Toxin for the Treatment of Focal Spasticity and Dystonia: A Systematic Review.
Grigoriu AI; Dinomais M; Rémy-Néris O; Brochard S
Arch Phys Med Rehabil; 2015 Nov; 96(11):2067-78.e1. PubMed ID: 25982240
[TBL] [Abstract][Full Text] [Related]
9. [Botulinum toxin for postoperative care after limb surgery in cerebral palsy children].
Dohin B; Garin C; Vanhems P; Kohler R
Rev Chir Orthop Reparatrice Appar Mot; 2007 Nov; 93(7):674-81. PubMed ID: 18065878
[TBL] [Abstract][Full Text] [Related]
10. Peri-operative Botulinum Neurotoxin injection to improve outcomes of surgeries on spastic limbs: A systematic review.
Saeidiborojeni S; Mills PB; Reebye R; Finlayson H
Toxicon; 2020 Dec; 188():48-54. PubMed ID: 33045238
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation.
Bjornson K; Hays R; Graubert C; Price R; Won F; McLaughlin JF; Cohen M
Pediatrics; 2007 Jul; 120(1):49-58. PubMed ID: 17606561
[TBL] [Abstract][Full Text] [Related]
12. Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin.
Koman LA; Paterson Smith B; Balkrishnan R
Paediatr Drugs; 2003; 5(1):11-23. PubMed ID: 12513103
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
Buyukavci R; Akturk S; Ersoy Y
Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
[TBL] [Abstract][Full Text] [Related]
14. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal Baclofen Infusion-Botulinum Toxin Combined Treatment Efficacy in the Management of Spasticity due to Cerebral Palsy.
Marvulli R; Lagioia G; Ianieri G; Dell'Olio L; Zonno A; Riccardi M; Sinisi RB; Rizzo LB; Farì G; Megna M; Ranieri M
CNS Neurol Disord Drug Targets; 2024; 23(7):917-926. PubMed ID: 38213169
[TBL] [Abstract][Full Text] [Related]
16. The effect of spasticity on cortical somatosensory-evoked potentials: changes of cortical somatosensory-evoked potentials after botulinum toxin type A injection.
Park ES; Park CI; Kim DY; Kim YR
Arch Phys Med Rehabil; 2002 Nov; 83(11):1592-6. PubMed ID: 12422331
[TBL] [Abstract][Full Text] [Related]
17. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity induced by botulinum toxin injections for limb spasticity: A systematic review.
Mathevon L; Declemy A; Laffont I; Perennou D
Ann Phys Rehabil Med; 2019 Jul; 62(4):241-251. PubMed ID: 30980953
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy.
Ade-Hall RA; Moore AP
Cochrane Database Syst Rev; 2000; (2):CD001408. PubMed ID: 10796784
[TBL] [Abstract][Full Text] [Related]
20. The effect of neural lesion type on botulinum toxin dosage: a retrospective chart review.
Phadke CP; Davidson C; Ismail F; Boulias C
PM R; 2014 May; 6(5):406-11. PubMed ID: 24211697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
